The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Pedyshov V.S.

Krasnoyarsk Interdistrict Children's Hospital No. 4

Gritsyn A.I.

Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky Ministry of Health of Russia;
Krasnoyarsk Regional Center for Medical Education

Malignant hyperthermia patients register foundation

Authors:

Pedyshov V.S., Gritsyn A.I.

More about the authors

Read: 243 times

To cite this article:

Pedyshov VS, Gritsyn AI. Malignant hyperthermia patients register foundation. Russian Journal of Anesthesiology and Reanimatology. 2025;(6):132‑133. (In Russ.)

References:

  1. Lebedinskii KM, Prokopiev GG, Stepanenko SM, Dunts PV, Molchanov IV, Ovechkin AM, Alexandrovich YuS, Lomivorotov VV, Shen NP, Trembach AV, Zolotukhin KN, Pichugin VV, Boronina IV, Diordiev AV, Rostovtsev SI. Malignant hyperthermia due to anaesthesia. Russian Journal of Anaesthesiology and Reanimatology. 2023;6:6-18. (In Russ.). https://doi.org/10.17116/anaesthesiology20230616
  2. MacLennan DH, Phillips MS. Malignant hyperthermia. Science. 1992; 256(5058):789-794 
  3. Riazi S, Kraeva N, Hopkins PM. Malignant Hyperthermia in the Post-Genomics Era New Perspectives on an Old Concept. Anesthesiology. 2018;28:168-180.  https://doi.org/10.1097/ALN.0000000000001878
  4. Horstick EJ, Linsley JW, Dowling JJ, et al. Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. Nature Communications. 2013;4:1952. https://doi.org/10.1038/ncomms2952
  5. Larach M. G. A Primer for Diagnosing and Managing Malignant Hyperthermia Susceptibility. Anesthesiology. 2018;128:8-10.  https://doi.org/10.1097/ALN.0000000000001879
  6. Gong X. Malignant hyperthermia when dantrolene is not readily available.BMC Anesthesiology. 2021;21:1-11.  https://doi.org/10.1186/s12871-021-01328-3
  7. Hopkins PM. Malignant hyperthermia: pharmacology of triggering. British Journal of Anaesthesia. 2011;107:48-56. 
  8. Glahn KP, Ellis FR, Halsall PJ, Müller CR, Snoeck MM, Urwyler A, Wappler F; European Malignant Hyperthermia Group. Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. British Journal of Anaesthesia. 2010;105:417-420.  https://doi.org/10.1093/bja/aeq243
  9. Kim D-C. Malignant hyperthermia. Korean Journal of Anesthesiology. 2012;63(5):391-401.  https://doi.org/10.4097/kjae.2012.63.5.391
  10. Mayhew JF, Rudolph J, Tobey RE. Malignant hyperthermia in a six month old infant: a case report. Anesthesia & Analgesia. 1978;57(2):262-264.  https://doi.org/10.1213/00000539-197803000-00018
  11. Kim ES, Gorbachev VI, Unzhakov VV. Malignant hyperthermia: current approaches to prevention and treatment. Acta Biomedica Scientifica. 2017;5(2):154-158. (In Russ.). https://doi.org/10.12737/article_5a3a0ef02e9901.72007754

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.